Purpose-built for physicians GLP-1s reduce thrombosis risk among people with diabetes, regardless of obesity Key takeaways: Individuals who took GLP-1 receptor agonists for type 2 diabetes exhibited reduced risk for thrombosis
Patients should avoid purchasing unapproved GLP-1 patches marketed online, as these products may be counterfeit or unsafe
Research suggests orlistat can support weight loss of around 4-8% after one year when combined with a reduced-calorie diet
Medicaid spending on GLP-1s has grown exponentially over the past five years, reflecting both an increase in GLP-1 usage and expanded coverage in many states
from there it passes into the blood stream
Where serum B12 results are borderline or do not fit the clinical picture, further tests such as active B12 (holotranscobalamin), methylmalonic acid, or homocysteine may be helpful